Wird geladen …
Cost-Effectiveness of Dapagliflozin versus Acarbose as a Monotherapy in Type 2 Diabetes in China
OBJECTIVE: To estimate the long-term cost-effectiveness of dapagliflozin versus acarbose as monotherapy in treatment-naïve patients with type 2 diabetes mellitus (T2DM) in China. METHODS: The Cardiff Diabetes Model, an economic model designed to evaluate the cost-effectiveness of comparator therapie...
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Online Artikel Text |
| Sprache: | English |
| Veröffentlicht: |
Public Library of Science
2016
|
| Schlagworte: | |
| Online Zugang: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091768/ https://www.ncbi.nlm.nih.gov/pubmed/27806087 http://dx.doi.org/10.1371/journal.pone.0165629 |